神济昌华（北京）生物科技有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Novel Gene Therapy for ALS cleared for global trials in China and the U.S. 2025-08-15 19:00
SineuGene's SNUG01 Receives FDA Orphan Drug Designation for ALS 2025-06-26 22:04
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS 2025-03-24 20:00
1